Skip to main content
49°
Rain Shower
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Irhythm Technologies Inc
(NQ:
IRTC
)
73.90
+0.16 (+0.22%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Irhythm Technologies Inc
< Previous
1
2
3
4
5
6
Next >
iRhythm Technologies to Participate in the Citi 2024 Global Healthcare Conference
November 20, 2024
From
iRhythm
Via
GlobeNewswire
iRhythm Data Presented at the American Heart Association 2024 Scientific Sessions Reinforce Clinical and Health Economic Value of Zio Long-Term Continuous Monitoring
November 18, 2024
Five new studies span three focus areas for LTCM devices: digital engagement and patient satisfaction, arrhythmia patterns during sleep and activity, and the potential health care resource and economic...
From
iRhythm
Via
GlobeNewswire
iRhythm Technologies to Participate in the Wolfe Research 2024 Healthcare Conference
November 05, 2024
From
iRhythm
Via
GlobeNewswire
IRHYTHM ALERT: Bragar Eagel & Squire, P.C. is Investigating iRhythm Technologies, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
November 01, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
iRhythm Technologies Receives FDA 510(k) Clearance for Design Modifications to Its Zio® AT Device
October 30, 2024
From
iRhythm
Via
GlobeNewswire
iRhythm Technologies Announces Third Quarter 2024 Financial Results
October 30, 2024
From
iRhythm
Via
GlobeNewswire
Newly Published Research Shows 14-Day Monitoring Detected Almost Three Times More Nonsustained Ventricular Tachycardia Than Standard 48-Hour Monitoring in Patients with Hypertrophic Cardiomyopathy
October 28, 2024
From
iRhythm
Via
GlobeNewswire
IRHYTHM INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of iRhythm Technologies, Inc. - IRTC
October 25, 2024
From
Kahn Swick & Foti, LLC
Via
Business Wire
iRhythm Technologies Receives FDA 510(k) Clearance for Design Updates Previously Made to Its Zio® AT Device
October 21, 2024
Zio AT device, along with the Zio ECG Utilization Software (ZEUS) (K222389), enables the provision of ambulatory Mobile Cardiac Telemetry (MCT) monitoring service for non-critical care patients
From
iRhythm
Via
GlobeNewswire
iRhythm Technologies to Report Third Quarter 2024 Financial Results on October 30, 2024
October 16, 2024
From
iRhythm
Via
GlobeNewswire
IRHYTHM INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of iRhythm Technologies, Inc. - IRTC
September 30, 2024
From
Kahn Swick & Foti, LLC
Via
Business Wire
iRhythm Technologies Announces Japanese Regulatory Approval of the Zio® ECG Monitoring System, the First Product to Deliver Arrhythmia Monitoring Service Utilizing Artificial Intelligence
September 11, 2024
From
iRhythm
Via
GlobeNewswire
iRhythm Unveils Data Demonstrating Superior Real-World Performance of Next-Generation Zio® Monitor at HRX 2024 Meeting
September 09, 2024
From
iRhythm
Via
GlobeNewswire
iRhythm Technologies Enters License Agreement with BioIntelliSense for Multiparameter Sensor Technology to be Used in Ambulatory Cardiac Monitoring
September 04, 2024
iRhythm granted exclusive license to BioIntelliSense’s patented pulse oximetry, accelerometry and trending non-invasive blood pressure technologies for use within ambulatory cardiac monitoring (ACM)...
From
iRhythm
Via
GlobeNewswire
iRhythm Technologies Announces Results of GUARD-AF Trial
September 01, 2024
From
iRhythm
Via
GlobeNewswire
iRhythm Technologies Expands Global Reach with the Launch of Zio® Cardiac Arrhythmia Monitoring Service in Austria, the Netherlands, Switzerland, and Spain
August 29, 2024
From
iRhythm
Via
GlobeNewswire
iRhythm Technologies to Participate in Upcoming Investor Conferences in September
August 21, 2024
From
iRhythm
Via
GlobeNewswire
iRhythm Technologies Announces Chief Financial Officer Transition
August 01, 2024
From
iRhythm
Via
GlobeNewswire
iRhythm Technologies Announces Second Quarter 2024 Financial Results
August 01, 2024
From
iRhythm
Via
GlobeNewswire
iRhythm Technologies to Report Second Quarter 2024 Financial Results on August 1, 2024
July 18, 2024
From
iRhythm
Via
GlobeNewswire
iRhythm Technologies Achieves Significant Operational Milestone with Launch of Initial Phase of Manufacturing Automation
June 17, 2024
From
iRhythm
Via
GlobeNewswire
iRhythm Technologies to Present at the 2024 Truist Securities MedTech Conference
June 04, 2024
From
iRhythm
Via
GlobeNewswire
iRhythm Technologies to Present at the William Blair 44th Annual Growth Stock Conference
May 22, 2024
From
iRhythm
Via
GlobeNewswire
IRHYTHM ALERT: Bragar Eagel & Squire, P.C. is Investigating iRhythm Technologies, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
May 21, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
iRhythm Technologies Announces First Quarter 2024 Financial Results
May 02, 2024
From
iRhythm
Via
GlobeNewswire
iRhythm Technologies to Report First Quarter 2024 Financial Results on May 2, 2024
April 18, 2024
From
iRhythm
Via
GlobeNewswire
IRTC DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages iRhythm Technologies, Inc. Investors to Secure Counsel Before Important April 8 Deadline in Securities Class Action – IRTC
April 08, 2024
From
The Rosen Law Firm PA
Via
GlobeNewswire
IRTC DEADLINE TODAY: ROSEN, A RANKED AND LEADING FIRM, Encourages iRhythm Technologies, Inc. Investors to Secure Counsel Before Important April 8 Deadline in Securities Class Action – IRTC
April 08, 2024
From
The Rosen Law Firm, P.A.
Via
Business Wire
IRTC DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages iRhythm Technologies, Inc. Investors to Secure Counsel Before Important April 8 Deadline in Securities Class Action - IRTC
April 07, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
IRTC DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages iRhythm Technologies, Inc. Investors to Secure Counsel Before Important April 8 Deadline in Securities Class Action - IRTC
April 07, 2024
WHY: NEW YORK, NY - (NewMediaWire) - April 07, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of iRhythm Technologies, Inc. (NASDAQ: IRTC) between January...
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.